Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos
K
Stavropoulos
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos P
KP
Imprialos
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Chrysoula
C
Boutari
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Vasilios G
VG
Athyros
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Asterios I
AI
Karagiannis
D001786:Blood Glucose; D000068896:Canagliflozin; D003924:Diabetes Mellitus, Type 2; D004311:Double-Blind Method; D005960:Glucosides; D006442:Glycated Hemoglobin; D006801:Humans; D006973:Hypertension; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2
D001786:Blood Glucose; D000068896:Canagliflozin; D005960:Glucosides; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2